Wilms' tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Wilms' tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives.
- Published In:
- Human vaccines & immunotherapeutics, 20(1), 2296735 (2024)
- Authors:
- Ogasawara, Masahiro
- Database ID:
- RPEP-08976
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08976APA
Ogasawara, Masahiro. (2024). Wilms' tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives.. Human vaccines & immunotherapeutics, 20(1), 2296735. https://doi.org/10.1080/21645515.2023.2296735
MLA
Ogasawara, Masahiro. "Wilms' tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives.." Human vaccines & immunotherapeutics, 2024. https://doi.org/10.1080/21645515.2023.2296735
RethinkPeptides
RethinkPeptides Research Database. "Wilms' tumor 1 -targeting cancer vaccine: Recent advancement..." RPEP-08976. Retrieved from https://rethinkpeptides.com/research/ogasawara-2024-wilms-tumor-1-targeting
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.